Author

Donna M. Reidlinger

Observed names: D Reidlinger, D. Reidlinger, DM Reidlinger, Donna Reidlinger, Reidlinger, Donna, Reidlinger, Donna M.

Institution: The University of Queensland

Observed institutions: The University of Sydney, Translational Research Institute, The University of Queensland, The George Institute for Global Health, Population Health Research Institute, UNSW Sydney, The George Institute for Global Health, St George Hospital, Westmead Institute for Medical Research, Hamilton Health Sciences, McMaster University

ORCID: 0000-0002-3365-9923

Observed ORCID: 0000-0002-3365-9923

OpenAlex ID: A5038007882

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

2020 · Michael Walsh, Peter A. Merkel, et al. · New England Journal of Medicine · 897

PDF

Effects of Allopurinol on the Progression of Chronic Kidney Disease

2020 · Sunil V. Badve, Elaine M. Pascoe, et al. · New England Journal of Medicine · 477

PDF

A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

2020 · Nigel D. Toussaint, Eugenia Pedagogos, et al. · Journal of the American Society of Nephrology · 90

Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial

2023 · Michael G Collins, Magid A Fahim, et al. · The Lancet · 87

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial

2015 · Matthew A. Roberts, Helen L. Pilmore, et al. · American Journal of Kidney Diseases · 44

Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals

2020 · Patrizia Natale, Talia Gutman, et al. · Nephrology Dialysis Transplantation · 41

PDF

A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial

2014 · David W. Johnson, Elaine M. Pascoe, et al. · American Journal of Kidney Diseases · 40

Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial

2023 · B Logan, AK Viecelli, et al. · Trials · 35

PDF

Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation

2020 · Michael G. Collins, Magid A. Fahim, et al. · Trials · 25

PDF

Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes (TEACH-PD): A feasibility study

2020 · Josephine SF Chow, Kelly Adams, et al. · Peritoneal Dialysis International · 22

Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops

2019 · Talia Gutman, Allison Tong, et al. · Nephrology Dialysis Transplantation · 22

The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

2024 · Balazs Odler, Regina Riedl, et al. · Kidney International · 20

Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network

2013 · Alicia T. Morrish, Carmel M. Hawley, et al. · Kidney International · 18

Perspectives of a proposed patient navigator programme for people with chronic kidney disease in rural communities: Report from national workshops

2022 · Nicole Scholes‐Robertson, Martin Howell, et al. · Nephrology · 15

Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

2016 · Joel Gummer, Robert Trengove, et al. · Nephrology · 15

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT

2022 · David Jayne, Michael Walsh, et al. · Health Technology Assessment · 13

PDF

‘Knowledge is power’: A framework for partnering with consumers in developing and delivering a scientific meeting in nephrology

2019 · Emily Duncanson, Kathryn Dansie, et al. · Nephrology · 12

Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol

2023 · Josephine S. F. Chow, Neil Boudville, et al. · Trials · 11

PDF

Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning

2022 · Donna M. Reidlinger, David W. Johnson, et al. · Kidney International · 11

PDF

Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response

2021 · on behalf of the Australasian Kidney Trials Network, Laura Robison, et al. · Trials · 11

PDF

Screening and Management Practices for Polyoma (BK) Viremia and Nephropathy in Kidney Transplant Recipients From the Lands Down Under: Addressing the Unknowns and Rationale for a Multicenter Clinical Trial

2020 · Germaine Wong, Julie Marsh, et al. · Kidney International Reports · 11

PDF

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

2015 · Lei Zhang, Jeff Coombes, et al. · Redox Report · 10

PDF

Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial

2015 · Sunil V. Badve, Lei Zhang, et al. · Canadian Journal of Kidney Health and Disease · 10

PDF

Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation

2022 · Michael G. Collins, Magid A. Fahim, et al. · Transplantation Direct · 9

Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start

2022 · Katharine Hegerty, Allison Jaure, et al. · Kidney International Reports · 8

PDF

Works count: 70

Citation count: 2,001

H-index: 15

I10-index: 23